Article Details
Retrieved on: 2022-05-24 16:11:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Goldman Sachs has increased the price target on SpringWorks Therapeutics (SWTX) on Tuesday after the clinical-stage biotech reported positive data ...
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here